Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma
Latest Information Update: 20 Jan 2025
Price :
$35 *
At a glance
- Drugs Ceritinib (Primary) ; Pazopanib (Primary) ; Ribociclib (Primary) ; Trametinib (Primary)
- Indications Acral lentiginous melanoma; Malignant melanoma; Uveal melanoma
- Focus Therapeutic Use
- Acronyms MatchMel
- 20 Jan 2025 New trial record